These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 1359451)
21. Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats. Carta AR; Fenu S; Pala P; Tronci E; Morelli M Eur J Neurosci; 2003 Nov; 18(9):2563-72. PubMed ID: 14622157 [TBL] [Abstract][Full Text] [Related]
22. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion. Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981 [TBL] [Abstract][Full Text] [Related]
23. Involvement of dopamine D1 and D2 receptors in Fos immunoreactivity induced by stepholidine in both intact and denervated striatum of lesioned rats. Guo X; Ding YM; Hu JY; Jin GZ Life Sci; 1998; 62(25):2295-302. PubMed ID: 9651118 [TBL] [Abstract][Full Text] [Related]
24. Differing influences of dopamine agonists and antagonists on Fos expression in identified populations of globus pallidus neurons. Ruskin DN; Marshall JF Neuroscience; 1997 Nov; 81(1):79-92. PubMed ID: 9300403 [TBL] [Abstract][Full Text] [Related]
25. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation. Hu XT; Wachtel SR; Galloway MP; White FJ J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947 [TBL] [Abstract][Full Text] [Related]
26. Intrastriatally injected c-fos antisense oligonucleotide interferes with striatonigral but not striatopallidal gamma-aminobutyric acid transmission in the conscious rat. Sommer W; Rimondini R; O'Connor W; Hansson AC; Ungerstedt U; Fuxe K Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14134-9. PubMed ID: 8943073 [TBL] [Abstract][Full Text] [Related]
27. The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression. Marshall JF; Henry BL; Billings LM; Hoover BR Neuroscience; 2001; 105(2):365-78. PubMed ID: 11672604 [TBL] [Abstract][Full Text] [Related]
28. D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats. Ruskin DN; Marshall JF Brain Res; 1995 Dec; 703(1-2):156-64. PubMed ID: 8719628 [TBL] [Abstract][Full Text] [Related]
29. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists. McPherson RJ; Marshall JF Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899 [TBL] [Abstract][Full Text] [Related]
31. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. Gerfen CR; Keefe KA; Gauda EB J Neurosci; 1995 Dec; 15(12):8167-76. PubMed ID: 8613751 [TBL] [Abstract][Full Text] [Related]
32. 6-Hydroxydopamine lesions of the nigrostriatal pathway alter the expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons. Kincaid AE; Albin RL; Newman SW; Penney JB; Young AB Neuroscience; 1992 Dec; 51(3):705-18. PubMed ID: 1488118 [TBL] [Abstract][Full Text] [Related]
33. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Cole DG; Kobierski LA; Konradi C; Hyman SE Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819 [TBL] [Abstract][Full Text] [Related]
34. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ; Marshall JF Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762 [TBL] [Abstract][Full Text] [Related]
37. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors. Wang JQ; McGinty JF J Pharmacol Exp Ther; 1997 May; 281(2):972-82. PubMed ID: 9152408 [TBL] [Abstract][Full Text] [Related]
38. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Weick BG; Walters JR Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219 [TBL] [Abstract][Full Text] [Related]
39. Caffeine-mediated induction of c-fos, zif-268 and arc expression through A1 receptors in the striatum: different interactions with the dopaminergic system. Dassesse D; Vanderwinden JM; Goldberg I; Vanderhaeghen JJ; Schiffmann SN Eur J Neurosci; 1999 Sep; 11(9):3101-14. PubMed ID: 10510174 [TBL] [Abstract][Full Text] [Related]
40. Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour. Ferré S; Rimondini R; Popoli P; Reggio R; Pèzzola A; Hansson AC; Andersson A; Fuxe K Eur J Neurosci; 1999 Nov; 11(11):3884-92. PubMed ID: 10583477 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]